Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Medicines for Eye and CNS Diseases
Paris, France – May 21, 2025 – Coave Therapeutics ('Coave'), a company pioneering the future of genetic medicines, today announces the evolution of its Scientific Advisory Board (SAB). This renewed SAB reflects Coave's strategic shift from a platform-focused approach to the development of a therapeutic pipeline, as the Company advances multiple gene therapy programs. The SAB brings together internationally recognized leaders in adeno-associated viral (AAV) vector biology, gene therapy development for ophthalmology and central nervous system (CNS) diseases, and innovative approaches to extra-hepatic gene delivery.
The SAB members include:
Olivier Danos, PhD (Chair) – Chief Scientific Officer at REGENXBIO (Rockville, MD, USA)
Dr. Danos is a pioneer in gene therapy with over 30 years of academic and industrial leadership, including roles at Biogen, Genethon and University College London, and now leads REGENXBIO's scientific strategy
Robin Ali, PhD – Professor of Human Molecular Genetics at King's College London (London, UK) and Founder of MeiraGTx
Dr. Ali is a world-leading expert in gene therapy for retinal diseases and a pioneer of translational research advancing vision restoration therapies
Aravind Asokan, PhD – Professor at Duke University School of Medicine and Director of the Danaher Beacon for Gene Therapy Innovation (Durham, NC, USA)
Dr. Asokan specializes in AAV vector biology and synthetic virology, developing engineered AAVs to enable next-generation gene therapies
Juliette Hordeaux, DVM, PhD – Chief Scientific Officer at GEMMA Biotherapeutics (Philadelphia, PA, USA) and formerly Executive Director of Translational Research at the Gene Therapy Program, University of Pennsylvania (Philadelphia, PA, USA)
Dr. Hordeaux is a recognized leader in the development of AAV-based CNS-targeted gene therapies, focused on translating preclinical innovations to clinical-stage programs
Federico Mingozzi, PhD – Chief Executive Officer of Nava Therapeutics (Philadelphia, PA, USA)
Dr. Mingozzi brings extensive expertise in gene therapy R&D and translation, having previously served as Chief Scientific Officer at Spark Therapeutics and earlier led programs at Genethon, INSERM and the Children's Hospital of Philadelphia
Amy Pooler, PhD – Senior Vice President, Research and Development at Life Edit Therapeutics (Durham, NC, USA), previously Vice President, Head of Research at Sangamo Therapeutics (Brisbane, CA, USA)
Dr. Pooler has extensive experience in translational neuroscience and genetic medicine, with leadership roles in developing CNS-targeted therapies at Sangamo and Life Edit
The SAB members will provide strategic scientific and clinical guidance to support Coave's R&D initiatives, leveraging its ALIGATER™ (Advanced Vectors-Ligand Conjugates) platform to unlock improved precision and safety in genetic medicine. Their combined expertise strengthens Coave's leadership in developing AAV-based therapeutics targeting diseases beyond the liver, including the eye and CNS.
Lolita Petit, CSO of Coave Therapeutics commented, 'We are absolutely delighted to welcome this exceptional group of world-leading experts to our Scientific Advisory Board. Their collective expertise across AAV biology, gene therapy development and translational research will be invaluable as we continue to enhance our ALIGATER™ platform and advance our therapeutic pipeline. Their support reinforces our commitment to delivering next-generation genetic medicines with improved precision and safety and accelerates our mission to transform the lives of patients with serious unmet medical needs.'
***
Photos of SAB members available on request
About ALIGATER™Coave's proprietary ALIGATER™ (Advanced Vectors-Ligand Conjugates) platform is a breakthrough technology addressing key limitations in the delivery of genetic payloads to extra-hepatic tissues, including limited tissue specificity, delivery efficiency and safety. ALIGATER™ enables conjugation of targeting ligands, such as small molecules, peptides, or antibody fragments, on AAV or non-viral vectors, offering superior delivery efficiency, tissue specificity and safety profile for a broad range of diseases. Importantly, the platform streamlines the manufacturing process by avoiding prior AAV capsid modifications. These capabilities will enable Coave to develop best-in-class gene therapies designed for specific indications.
About Coave Therapeutics Coave Therapeutics is a genetic medicine company pioneering the development of innovative solutions to enhance the precision, safety, efficacy and manufacturability of genetic medicines. With its proprietary ALIGATER™ platform, Coave is at the forefront of addressing challenges in gene therapy delivery to extra-hepatic tissues, creating a robust pipeline targeting CNS, neuromuscular and eye diseases.
Headquartered in Paris, France, Coave Therapeutics is backed by leading international life sciences investors. For more information about the science, pipeline, and people, please visit coavetx.com and follow us on LinkedIn.
CONTACTS
Coave Therapeutics Rodolphe Clerval, CEO contact@coavetx.com
MEDiSTRAVA Sylvie Berrebi, Mark Swallow coavetx@medistrava.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
"Amen" at the end of the long day: Laid-off workers seek community and solace online
When Melanie Ehrenkranz, the founder of the 'Laid Off' Substack newsletter, launched her newsletter for unemployed workers in August 2024, she didn't expect to create a vibrant, active community of over 11,000 readers in less than a year. In addition to the newsletter, Ehrenkranz also runs a Discord community, which offers its members additional ways to connect, support each other and navigate the uncharted waters of unemployment during the second Trump term. This community is private for paid readers at the monthly fee of $5. While the particular kind of financial strain and psychological pressures that characterize unemployment have been around as long as there have been jobs, the scale of layoffs, the transformative nature of AI that is upending entire industries, stubborn inflation, economic uncertainty and new ways social media is connecting people again post-pandemic makes 2025 a unique time to be navigating the ever-shifting job market. 'This moment feels heavier,' Ehrenkranz told Salon. 'People aren't just getting laid off — they're getting ghosted, strung along, maybe even experiencing their second or third or fifth layoff in their career.' Magenta Fox, one of the members of the community Ehrenkranz created, has been laid off since 2023. Fox says this period of unemployment is 'vastly different' from the other times she was laid off, in 2009 and during 2016-2018. 'With this search, I've paid for resume rewrites and interview coaching— something I've never done at any point in my career,' Fox said. 'And it seems like there's no end in sight. At least with the Great Recession it seemed like there was an effort in Washington to try to make things better.' This time around, Fox found her interactions with recruiters more cutthroat. 'I've had recruiters no-show on calls and write rude emails— something I've never gotten from anyone, recruiter or no, in my professional life, ever,' she said. The uptick in ghosting behavior from recruiters adds to the mental health toll job hunting can take. 'The psychological effect was really enormous,' said New York-based Dio Martins, who has been recently laid off and has just landed a new remote opportunity. Martins found networking and connecting with friends helpful in his job search. 'It's incredible how helpful a little text message can be to someone, just reminding you that you're not alone, and to keep trying things,' he said. As of late May 2025, U.S. employers cut nearly half a million jobs, which is a 93% jump compared to the same period last year. So far, 2025 has been a brutal year for US employees. Major U.S. employers like Chevron, JPMorgan Chase, Microsoft, Meta Platforms, Blue Origin, Estée Lauder, Kohl's, Southwest Airlines, Walmart and Business Insider have announced major layoffs ranging from hundreds to thousands of jobs. Inspired by communities like Rachel Karten's Link in Bio Discord and Julia Harrison's Saloon Substack, Ehrenkranz wanted to remove the stigma from being unemployed and create a nurturing environment for those looking to get back on their feet. 'I noticed a lot of readers were using the Substack Chat to share their stories and ask for advice, and so I wanted to create a space that had more layers to it for people experiencing job loss to connect,' Ehrenkranz said. 'The intention behind the Discord, similar to the overall mission, is for people to feel less alone and to destigmatize layoffs. And also to have some fun and maybe make some friends.' Over time, she noticed that members started using the Discord as a way to deal with the day-to-day pressures of job searching, both online and in person. 'I've seen people in the Discord share advice on how to post about their layoff on LinkedIn without it feeling cringe, how to wear their hair in a Zoom job interview, how to respond to a hiring manager that ghosted them after several rounds of interviews, and how to tweak their resume so it doesn't get trashed by ATS software,' she said. 'I've also increasingly seen folks trying to meet up outside of the Discord, whether it's in a vent session on Google Meet or grabbing drinks during the week.' Ultimately, the mental health break and human connection is what online communities like 'Laid Off' offer its members: without the gloss or pretenses of traditional social media or the unproductive bureaucracy of an unemployment office. 'In this economy, finding full-time employment is like finding a needle in a haystack,' said 25-year-old Niya Doyle, one of the people Ehrenkranz profiled for her newsletter. Doyle made a TikTok about how she was laid off, one of many who turned to social media to seek solace from others going through the same experience. 'I just saw a lot of my FYP even before I got laid off,' she said. 'I guess it makes it feel like you're not alone. It's comforting.' Whether it's Substack comments, Reddit forums, Discord communities or TikTok posts detailing their layoff experiences, more job seekers are finding comfort in numbers on social media, making their isolating experience of a layoff a little bit more palatable. 'They're the co-workers I wish I had, in a way,' Fox said about the Laid Off community. 'We exchange tips and share rejection stories. I feel like I can go there to vent without being seen as a bummer.'
Yahoo
26 minutes ago
- Yahoo
Rusty Taco seeks liquor license in Rockford for first Illinois location
ROCKFORD, Ill. (WTVO) — , a Texas-based fast-food chain, is seeking a liquor license to open a location in Rockford. The company has multiple locations across the United States, but the Rockford restaurant would be . An application filed with the City of Rockford Liquor and Advisory Board requests a permit to sell liquor in conjunction with a sit-down restaurant to be located at 6905 E. State Street, at the corner of E. State and Perryville Road. The chain sells seafood, beef, chicken, pork, and vegetarian tacos and bowls, along with street taco bowls, burritos, breakfast tacos, breakfast bowls, nachos, deserts, and more. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
26 minutes ago
- Yahoo
Alaska Airlines to launch flights to Rome next year
Alaska Airlines is making its Europe debut with the launch of nonstop flights to Rome next year. The Seattle-based carrier will operate four weekly flights to and from its Pacific Northwest hub to the popular Italian city starting in May 2026. Flights from Seattle-Tacoma Internatinal Airport and Rome Fiumicino Leonardo da Vinci Airport will go on sale in the fall. The airline says it selected Rome as its first European destination because it's one of the 'most requested' destinations among its reward members. This will be the third long-haul international route Alaska will launch from its Seattle home base since acquiring Hawaiian Airlines and its fleet of long-haul jets in 2024. According to Alaska Airlines CEO Ben Minicucci, the carrier plans to expand its global reach, intending to fly to 12 international destinations on multiple continents by 2030. Last month, Alaska launched its inaugural flights to Tokyo's Narita International Airport. Flights to Seoul, South Korea, are up next, which start on Sept. 12. The new Seattle-Rome route will also double as the launch for Alaska's new flagship international Dreamliner experience on board the new Boeing 787-9 Dreamliner Jets, which is expected to include all-new business-class suites and amenities. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
